Jivan and NimbleGen Partner for Splice Array Market
Complete the form below to unlock access to ALL audio articles.
Jivan Biologics and NimbleGen Systems have announced their partnership to make Jivan’s splice variant array designs available on NimbleGen’s high-density microarray platform.
"Jivan is proud to offer its full product line on NimbleGen's flexible and robust microarray platform," said Dr. Subha Srinivasan, CEO of Jivan Biologics (Berkeley, CA).
"This partnership furthers our goal to become the platform-independent solution for high-throughput splice variant analysis."
Dr. Stanley Rose, President and CEO of NimbleGen Systems (Madison, WI), commented, "Our collaboration with Jivan provides yet another example of an emerging measure of genome function or activity being enabled by NimbleGen’s platform."
"This product line nicely complements our whole genome ChIP-chip, CGH, Comparative Genome Sequencing, and Expression offerings, and further expands our integrated analytical capabilities also known as High Definition Genomics."
